BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update
Go back to BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.14 +0.15 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.99 | 52 Week High | $10.98 | |||
| Open | $9.04 | 52 Week Low | $1.63 | |||
| Day High | $9.34 | P/E | N/A | |||
| Day Low | $8.91 | EPS | $-0.68 | |||
| Volume | 7,405,437 | |||||
